MYD Profitability Analysis: Margins, Return on Capital, Free Cash Flow, and More - Myriad Genetics Inc

Watchlist Manager

Watchlist

Price: 3.256 EUR 0.65% Market Closed

Market Cap: €292.7m

M	Myriad Genetics Inc XHAM:MYD	US
	Deutsche Bank AG MIL:DBK	DE
	Astra Otoparts Tbk PT IDX:AUTO	ID
	Vaxart Inc NASDAQ:VXRT	US
C	Constellation Software Inc XMUN:W9C	CA
	Plexus Corp F:PX4	US
F	FirstEnergy Corp F:FE7	US
	Atlanta Braves Holdings Inc F:E450	US
I	Invesco Ltd XBER:3IW	US
E	Erlebnis Akademie AG DUS:EAD	DE
D	DSM-Firmenich AG OTC:DSMFF	CH
U	United Microelectronics Corp SWB:UMCB	TW
	Boyd Gaming Corp NYSE:BYD	US
V	Vector Group Ltd F:VGR	US
N	Nextera Energy Inc F:FP3	US
	Lenovo Group Ltd HKEX:992	CN
	KDDI Corp F:DIP	JP

Profitability Summary

Myriad Genetics Inc's profitability score is Hidden . We take all the information about a company's profitability, such as its margins, capital efficiency, free cash flow generating ability, and more, and consolidate it into one single number: the profitability score. The higher the profitability score, the more profitable the company is.

Exceptional Gross Margin

70%

Strong 3Y Average Gross Margin

69%

Gross Margin is Increasing

69% > 70%

Negative Operating Margin

-8%

Negative 3Y Average Operating Margin

-14%

Operating Margin is Increasing

-23% > -8%

Negative Net Margin

-48%

Negative 3Y Average Net Margin

-32%

Declining Net Margin

-21% > -48%

Negative Free Cash Flow Margin

-3%

Negative 3Y Average Free Cash Flow Margin

-11%

Free Cash Flow Margin is Increasing

-22% > -3%

Negative ROE

-77%

Negative 3Y Average ROE

Negative 3Y Average ROIC